Cost-effectiveness and Efficacy of Different Physical Exercise Interventions (ExerMOT4Health)
Launched by UNIVERSITY OF CADIZ · May 17, 2024
Trial Information
Current as of February 18, 2025
Active, not recruiting
Keywords
ClinConnect Summary
Scientific evidence has demonstrated the effects of multicomponent physical exercise on the mental and physical health of community-dwelling older people. Despite this, the interest of some older people in exercise is low and even a low percentage of older people practice it with sufficient frequency and intensity to obtain benefits in their mental and physical health. Recent studies have demonstrated the importance of using motivational strategies to generate adherence to exercise, but there are still no studies with community-dwelling older adults. Furthermore, the Covid-19 pandemic has s...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • People from both sexes aged 60-75 years.
- • Not to have diseases and disabilities that limit to be part of exercise interventions or avoid measurements.
- • Not perform supervised moderate to vigorous physical activity \>30 minutes and \>3 days/week.
- • To be able to communicate without problems.
- • To be able to read and understand the aim of the project and informed consent form.
- • To have a smartphone, tablet or computer with internet connection.
- Exclusion Criteria:
- • Acute or terminal illness.
- • Myocardial infarction, coronary artery bypass grafting, angioplasty, angina, or other cardiac conditions in the past year.
- • Uncontrolled medical problems that the general practitioner considers would preclude patients from undertaking the exercise program (e.g., acute systemic illness such as pneumonia, acute rheumatoid arthritis, and acute or unstable heart failure).
- • Conditions requiring a specialized physical exercise program (e.g., uncontrolled epilepsy, significant neurological disease or impairment, inability to maintain an upright seated position or unable to move independently, multiple sclerosis, cancer, Parkinson's, Alzheimer's, or chronic obstructive pulmonary disease).
- • General practitioner-diagnosed hypertension that has not been controlled.
- • Uncontrolled Type I or Type II Diabetes.
- • History of major psychiatric illness including schizophrenia, generalized anxiety disorder, or depression according to the DSM-5.
- • Three or more self-reported falls in the last year.
- • Not wanting to complete the study or be assigned to the control group;
- • Be participating in another research study that may influence this project.
Trial Officials
Ana Carbonell Baeza, PhD
Principal Investigator
University of Cadiz
Pablo Jorge Marcos Pardo, PhD
Principal Investigator
Universidad de Almeria
About University Of Cadiz
The University of Cádiz, an esteemed academic institution located in Spain, is dedicated to advancing medical research and clinical innovation through rigorous scientific inquiry. With a strong emphasis on interdisciplinary collaboration, the university fosters an environment that promotes the development of novel therapeutic strategies and enhances patient care. As a clinical trial sponsor, the University of Cádiz is committed to upholding the highest ethical standards and regulatory compliance, ensuring the safety and efficacy of its research initiatives while contributing valuable insights to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Almería, Almeria, Spain
Puerto Real, Cadiz, Spain
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0